Core Viewpoint - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. is currently involved in an arbitration case with Regen Biotech, Inc. regarding a distribution contract dispute, which has significant implications for the company's financial performance and operational capabilities [2][3][4]. Arbitration Basic Situation - The company's subsidiary, Datuo Medical, initiated arbitration against Regen Biotech for breach of contract, seeking to confirm the validity of the exclusive agency agreement and claiming preliminary damages of RMB 1.6 billion [3]. - The arbitration case was accepted by the Shenzhen International Arbitration Court on August 7, 2025, with the case number (2025) Shen Guo Zhong She Wai 8781 [3]. - On September 10, 2025, the court issued a decision regarding emergency measures requested by Datuo Medical [3]. Arbitration Progress - On September 23, 2025, the arbitration court accepted a counterclaim from Regen Biotech regarding the distribution contract dispute [4]. Counterclaim Main Content - The counterclaim includes requests to terminate Datuo Medical's exclusive agency rights for AestheFill products in mainland China, confirm the termination of related agreements, and seek compensation for reasonable expenses incurred by Regen Biotech [5]. Impact on the Company - The arbitration has not yet been heard, and the final outcome remains uncertain, which will directly affect the company's profits in the current and future periods [6]. - As of now, Regen Biotech has not complied with the court's emergency decision, hindering Datuo Medical's ability to sell AestheFill products [7].

材股份有限公司（以下简称"公司"、"被申请人"或"反请求申请人"）之间 的承包经营合同纠纷为由就向上海仲裁委员会提起仲裁（以下简称"初始仲裁申 请"），初始仲裁申请的涉案金额暂计人民币31,038,283.00元。详情参见公司 于2025年4月23日在上海证券交易所网站（www.sse.com.cn）及《上海证券报》 （以下合称为"指定信息披露媒体"）上披露的《公司关于新增仲裁事项的公告》 （公告编号：临2025-012）。 反请求被申请人向反请求申请人赔偿律师代理费并承担本案反请求仲裁费，上海 仲裁委员会也已受理了该请求，有关该仲裁案件反请求的相关情况参见公司于 告编号：临2025-028）。 证券代码：900939 证券简称：汇丽B 公告编号：临2025-032 上海汇丽建材股份有限公司 关于仲裁进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 根据上海仲裁委员会的最新通知，该仲裁案件的首次开庭时间延至2025年9 月11日，开庭延期情况公司已在2025年半年度报告第五节"重要事项"下的"七、 重 ...

这起仲裁案件源于元生智汇与鼎盛投资签署的回购协议。根据《仙游县元生智汇科技有限公司厂房及配套设施转让回购协议书》约定，元生智汇需在2025年 7月13日前，以8.06亿元价格向鼎盛投资回购元生智汇产业园的土地使用权及建筑物。然而回购期限已过，元生智汇未能按时办理回购手续并支付相应款 项。 在这一担保链条中，春兴精工承担着关键的反担保责任。早在2021年，春兴精工与仙游县人民政府、鼎盛投资等各方签署了一系列协议，同意由鼎盛投资以 8.06亿元购买元生智汇产业园的土地及建筑物，并由元生智汇回租和回购。春兴精工还为仙游国财向元生智汇提供的回购及租金增信服务提供了反担保。如 果元生智汇最终败诉且未能履行仲裁裁决，仙游国财可能需要承担连带担保责任，进而触发春兴精工的反担保责任。在扣除已支付的3.99亿元保证金后，春 兴精工将面临4.07亿元的剩余回购本金支付压力。 子公司面临巨额仲裁申请 元生智汇近日收到福州仲裁委员会出具的《案件受理通知书》。申请人仙游县鼎盛投资有限公司要求元生智汇立即办理产业园土地使用权及建筑物回购手 续，并支付回购款8.06亿元。同时要求仙游县仙财国有资产投资营运有限公司对上述款项承担连带担保责任 ...

Core Viewpoint - The arbitration dispute between Shenzhen-listed company Huakong Saige and the government of Qitaihe City, Heilongjiang Province, has escalated, with both parties accusing each other of breach of contract regarding a lithium battery project that has stalled for four years [1][6][9]. Group 1: Background of the Dispute - The dispute originated in December 2019 when the Qitaihe government designated a lithium battery anode material project as a key investment initiative and signed an investment contract with Huakong Saige's subsidiary, Heilongjiang Aoyuan New Materials [6]. - The agreement included the government's commitment to provide 272,000 square meters of land and to construct a factory based on the company's design, while Huakong Saige was to build a production line with a capacity of 30,000 tons per year [6]. Group 2: Project Stagnation - The project quickly stalled after its initiation, with Huakong Saige publicly acknowledging in 2021 that the construction had not started due to pandemic-related factors [8]. - By 2023, the project had a remaining book balance of 5.206 million yuan, and the company indicated in its 2024 annual report that it had made impairment provisions, stating that the project was expected to remain suspended [9]. Group 3: Escalation of Arbitration - In June 2025, both the Qitaihe government and Huakong Saige initiated arbitration, each accusing the other of breach of contract, with the government claiming that Huakong Saige had not invested the pre-paid 50 million yuan, leading to a demand for the return of funds and breach of contract penalties [9]. - Huakong Saige countered that the government failed to fulfill its obligations regarding land preparation and factory construction, seeking to reclaim the land and recover 48.89 million yuan in land transfer fees along with 7.52 million yuan in invested losses [9]. Group 4: Financial Implications - As of August 2025, the Qitaihe government increased its arbitration claim to a total of 23.96246 million yuan, which represents approximately 17.6% of Huakong Saige's revenue of 136 million yuan in the first quarter of 2025 [11][12]. - If Huakong Saige loses the arbitration, it could face significant financial pressure, exacerbating its already challenging financial situation, as the company reported a net loss of 17.37 million yuan in the same quarter [12].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或者重大 遗漏。 2025年8月4日，公司收到七台河仲裁委邮寄的《增加仲裁申请书》。 二、增加仲裁申请书的基本内容 2.上市公司及子公司所处的当事人地位：仲裁被申请人； 3.涉案金额：2,396.246万元； 4.对上市公司的影响：目前案件尚未开庭，该仲裁事项对公司本期利润或期后利润的具体影响尚存在不 确定性。 一、案件进展情况 七台河市新兴区人民政府就与深圳华控赛格股份有限公司（以下简称"公司"或"华控赛格"）及子公司黑 龙江奥原新材料有限公司（以下简称"黑龙江奥原"）签订的《七台河市锂离子电池负极材料项目投资合 同》所产生的纠纷问题，向七台河仲裁委员会（以下简称"七台河仲裁委"）申请仲裁。有关本次仲裁案 件的详细情况详见公司分别于2025年6月27日、2025年7月25日在指定信息披露媒体发布的《关于公司及 子公司收到〈仲裁申请书〉的公告》（公告编号：2025-32）《关于仲裁进展暨收到〈反请求受理通知 书〉的公告》（公告编号：2025-39）。 特别提示： 1.案件所处的仲 ...